EGFR-targeted treatments: insights from the adjuvant to the resistant setting
EGFR-targeted treatments: insights from the adju
Preface – ASCO 2017
Preface – ASCO 2017 Anna Nowak, MBBS FRACP Ph
Distinct somatic genome variations in young lung cancer patients
Distinct somatic genome variations in young lung
Comprehensive sequencing of plasma cell-free DNA permits non-invasive cancer detection
Comprehensive sequencing of plasma cell-free DNA
Recent benchmarks in the management of small-cell tumours
Recent benchmarks in the management of small-cel
ALK-positive disease: pushing the borders of treatability
ALK-positive disease: pushing the borders of tre
Interview with Barbara Melosky: “The sequencing question remains”
Interview with Barbara Melosky: “The sequencing
New data on EGFR-directed TKIs across 3 generations
New data on EGFR-directed TKIs across 3 generati
Immune checkpoint blockade: determinants of treatment success
Immune checkpoint blockade: determinants of trea
PD-(L)1 inhibition alone and in combination: recent insights into immunotherapy
PD-(L)1 inhibition alone and in combination: rec
